Digital transformation experts had high hopes for this year. Did these forecasts bear out, or have AI and a volatile economy proved a distraction? Sue Tabbitt, senior writer at Sarum Life Sciences, looks back.
Few would argue that 2025 has been a challenging year in life sciences, as global economic volatility and the sharp rise in AI use have disrupted strategic agendas.
“2025 has been a year where both geopolitics and the promise of AI have influenced the dynamics in this industry,” says Frits Stulp, partner for life sciences at Implement Consulting.
Check out the rest of the feature here





